1-7 of 7
Kavita Dhodapkar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Plasma Levels of IL7 and IL15 Predict Response to Chimeric Antigen Receptor T Cell Therapy (CAR-T) in Large B-Cell Lymphoma (LBCL) Patients

Fanyuan Zeng, Hanwen Zhang, Shuhua Wang, Tenzin Passang, Yiwen Helen Li, Christopher Ronald Funk, Sarah Wyman, Colin B O'Leary, Aseala I Abousaud, Yuan Liu, Kavita Dhodapkar, Edmund K. Waller, Jean L. Koff
Journal: Blood
Blood (2023) 142 (Supplement 1): 6112.
https://doi.org/10.1182/blood-2023-189248
Published: 2023
Journal Articles

Tumor-Immune Architecture and the Regulation of Antigen-Specific T-Cell Infiltration in Multiple Myeloma and Premalignant Plasma Cell Disorders

Hope Robinson, Nancy Villa, David L Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel McCachren, Julia Manalo, Jeffrey M. Switchenko, Ava Horvat, Vaunita C Parihar, Jingjing Gong, Yan Liang, Geoffrey Smith, Vikas A Gupta, Lawrence H. Boise, Jonathan L. Kaufman, Craig C Hofmeister, Nisha Joseph, Sagar Lonial, Kavita Dhodapkar, Madhav Dhodapkar
Journal: Blood
Blood (2022) 140 (Supplement 1): 244–245.
https://doi.org/10.1182/blood-2022-169558
Published: 2022
Journal Articles

Early Enrichment and Subsequent Dysfunction of Marrow ILC Subsets in Monoclonal Gammopathy: Target for IMiD Therapy

Jithendra Kini Bailur, PhD, Sameet Mehta, PhD, Lin Zhang, Natalia Neparidze, MD, Terri L Parker, MD, Noffar Bar, MD, Tara Anderson, PA, Mina Xu, MD, Kavita Dhodapkar, MBBS, Madhav V Dhodapkar, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4370.
https://doi.org/10.1182/blood.V130.Suppl_1.4370.4370
Published: 2017
Journal Articles

Identification of a Cereblon-Independent Protein Degradation Pathway in Residual Myeloma Cells Treated with Immunomodulatory Drugs

Rakesh Verma, PhD, Zifeng Mai, MS, Mina Xu, MD, Lin Zhang, Kavita Dhodapkar, MBBS, Madhav V Dhodapkar, MD
Journal: Blood
Blood (2015) 126 (23): 913.
https://doi.org/10.1182/blood.V126.23.913.913
Published: 2015
Journal Articles

Both Intermittent and Continuous Dosing Regimens Of Pomalidomide Mediate Broad Activation Of Innate and Adaptive Immunity In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Kavita Dhodapkar, MD, Lin Zhang, Rakesh Verma, Ph.D, Kartik Sehgal, MBBS, Mehmet H. Kocoglu, MD, Madhav V. Dhodapkar, MD
Journal: Blood
Blood (2013) 122 (21): 1949.
https://doi.org/10.1182/blood.V122.21.1949.1949
Published: 2013
Journal Articles

Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Kartik Sehgal, MBBS, Mehmet H. Kocoglu, MD, Yanhong Deng, Rakesh Verma, Ph.D, Lin Zhang, Dennis L. Cooper, MD, Xiaopan Yao, Kavita Dhodapkar, MD, Madhav V. Dhodapkar, MD
Journal: Blood
Blood (2013) 122 (21): 3205.
https://doi.org/10.1182/blood.V122.21.3205.3205
Published: 2013
Journal Articles

Enrichment Of Embryonal Stem Cell Signature and Persistent Genomic Complexity In Residual Disease Following Pomalidomide Therapy In Myeloma

Rakesh Verma, Ph.D, Kartik Sehgal, MBBS, Lin Zhang, Mehmet H. Kocoglu, MD, Kavita Dhodapkar, MD, Madhav V. Dhodapkar, MD
Journal: Blood
Blood (2013) 122 (21): 4200.
https://doi.org/10.1182/blood.V122.21.4200.4200
Published: 2013